高雄醫學大學圖書館 |

語系/ Language: 繁體中文

登入

回首頁

Hodgkin lymphomaa comprehensive over...

SpringerLink (Online service)

Hodgkin lymphomaa comprehensive overview /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Hodgkin lymphoma/ edited by Andreas Engert, Anas Younes.
其他題名:	a comprehensive overview /
其他作者:	Younes, Anas.
出版者:	Cham :Springer International Publishing : : 2020.,
版本:	Third edition.
面頁冊數:	ix, 509 p. :ill., digital ; : 24 cm.;
提要註:	This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL) Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
Contained By:	Springer eBooks
標題:	Oncology. -
電子資源:	https://doi.org/10.1007/978-3-030-32482-7
ISBN:	9783030324827

Hodgkin lymphomaa comprehensive overview /
Hodgkin lymphomaa comprehensive overview /[electronic resource] :edited by Andreas Engert, Anas Younes. - Third edition. - Cham :Springer International Publishing :2020. - ix, 509 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

Part I: Epidemiology and Pathogenesis -- Epidemiology of Hodgkin Lymphoma -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? -- Part II: Diagnosis and first-line treatment -- Clinical evaluation -- Functional imaging in Hodgkin Lymphoma -- Prognostic factors. - Principles of Radiation Therapy for Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Optimizing Decision Making in HL -- Part III: Special clinical situations -- Paediatric/adolescent Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- Part IV: Relapsed and refractory disease -- Relapsed and refractory Hodgkin Lymphoma -- Allogeneic transplantation for relapsed Hodgkin Lymphoma -- Targeting CD30 in Patients with Hodgkin Lymphoma -- Hodgkin Lymphoma and PD-1 blockade -- Other new agents for Hodgkin Lymphoma -- Part V: Survivorship -- Quality of Life in Hodgkin lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients -- Fatigue.

This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL) Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.

ISBN: 9783030324827

Standard No.: 10.1007/978-3-030-32482-7doiSubjects--Topical Terms:

273823
Oncology.

LC Class. No.: RC644 / .H634 2020

Dewey Class. No.: 616.9944606

Hodgkin lymphomaa comprehensive overview /
LDR:03727nam a2200349 a 4500 001 338187
003 DE-He213
005 20200806160158.0
006 m d
007 cr nn 008maaau
008 210622s2020 sz s 0 eng d
020 $a 9783030324827 $q (electronic bk.)
020 $a 9783030324810 $q (paper)
024 7 $a 10.1007/978-3-030-32482-7 $2 doi
035 $a 978-3-030-32482-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC644 $b .H634 2020
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.9944606 $2 23
090 $a RC644 $b .H689 2020
245 0 0 $a Hodgkin lymphoma $h [electronic resource] : $b a comprehensive overview / $c edited by Andreas Engert, Anas Younes.
250 $a Third edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a ix, 509 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
505 0 $a Part I: Epidemiology and Pathogenesis -- Epidemiology of Hodgkin Lymphoma -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? -- Part II: Diagnosis and first-line treatment -- Clinical evaluation -- Functional imaging in Hodgkin Lymphoma -- Prognostic factors. - Principles of Radiation Therapy for Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Optimizing Decision Making in HL -- Part III: Special clinical situations -- Paediatric/adolescent Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- Part IV: Relapsed and refractory disease -- Relapsed and refractory Hodgkin Lymphoma -- Allogeneic transplantation for relapsed Hodgkin Lymphoma -- Targeting CD30 in Patients with Hodgkin Lymphoma -- Hodgkin Lymphoma and PD-1 blockade -- Other new agents for Hodgkin Lymphoma -- Part V: Survivorship -- Quality of Life in Hodgkin lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients -- Fatigue.
520 $a This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL) Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
650 2 4 $2 96060 $a Oncology. $3 273823
650 1 4 $2 96060 $a Hematology. $3 240858
650 0 $a Hodgkin's disease. $3 465933
700 1 $a Younes, Anas. $3 465931
700 1 $a Engert, Andreas. $3 465930
710 2 $2 97100 $a SpringerLink (Online service) $3 255133
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 465932
856 4 0 $u https://doi.org/10.1007/978-3-030-32482-7
950 $a Medicine (Springer-11650)

筆 0 讀者評論

多媒體

評論

新增評論分享你的心得，請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論，館方有權利刪除任何違反評論規則之發言，情節嚴重者一律停權，以維護所有讀者的自由言論空間。

Export

取書館別